Notice of AGM and Posting of Annual Report 2021

RNS Number : 0613K
Accrol Group Holdings PLC
27 August 2021
 

 

27 August 2021

 

Accrol Group Holdings plc

("Accrol" or the "Group")

 

Notice of AGM and Posting of Annual Report 2021

 

Accrol Group Holdings plc, the UK's leading independent tissue converter, announces that its Annual Report for the year ended 30 April 2021, together with the Notice of its 2021 Annual General Meeting (AGM) are now available on the Group's website https://www.accrol.co.uk/investors/company-reports-presentations-and-circulars/  

 

Copies of both documents will be posted to shareholders later today.

 

The AGM is to be held at the Group's registered office at Delta Building, Roman Road, Blackburn BB1 2LD at 10:00am on 24 September 2021.

 

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

Richard Newman, Chief Financial Officer

 

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000



Liberum Capital Limited (Joint Broker)

Tel: +44 (0) 20 3100 2222

Clayton Bush / Edward Thomas




Belvedere Communications Limited

 

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525


accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the £2.1bn UK retail tissue market.

 

For more information, please visit www.accrol.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOALDLFLFVLLBBV
UK 100